Colon Cancer Screening

This study is currently active

The Guardant LUNAR-2 Test has been developed to detect malignant screen-relevant patients who would otherwise undergo screening for malignant diseases using invasive testing such as colonoscopy for colon cancer. If you are age 60-84 and scheduled to receive a colonoscopy within 60 days of the screening blood draw you would qualify for this trial. Many do not prefer the current required testing for colon cancer. This blood test would be the first step in identifying any cancer traits.

No cost to participate, and compensation for a single blood draw up to $74.

MUST HAVE A COLONOSCOPY SCHEDULED WITHIN 60 DAYS OF BLOOD TEST.

Participate in a Study

Submit the form and a clinical study expert will get in touch with you.

Want to know more about our clinical trials?